Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,611.00
Bid: 1,611.00
Ask: 1,611.50
Change: -1.00 (-0.06%)
Spread: 0.50 (0.031%)
Open: 1,607.50
High: 1,611.00
Low: 1,594.00
Prev. Close: 1,612.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks advance as investors shrug off weak data

Thu, 21st Aug 2014 12:01

- Mining stocks fall as Chinese data weakens- Eurozone PMIs and UK retail sales disappoint- US data, Jackson Hole aheadtechMARK 2,810.76 +0.50%FTSE 100 6,772.04 +0.25%FTSE 250 15,797.15 +0.31%Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursday despite a barrage of weak economic data from across the globe."The data seen so far today hasn't been great but that hasn't affected investors' appetite for risk, as European indices have continued their march higher," said market analyst Craig Erlam from Alpari UK.London's Footsie was trading 0.25% higher at 6,772 by midday.Economic data misses forecastsMining stocks were under pressure in morning trade after manufacturing data from top metals consumer China disappointed, while metals prices weakened on the back of a stronger US dollar.The HSBC China manufacturing purchasing managers' index (PMI) dropped from 51.7 to a three-month low 50.3 in August. The fall ended a streak of four straight monthly improvements in activity growth and disappointed analysts looking for a slight dip to 51.5.The Eurozone composite PMI, which measures activity in both manufacturing and services, fell from 53.8 to 52.8 in August, missing the 53.4 forecast as readings from both sectors came in below expectations.Closer to home, UK retail sales growth came in at just 0.1% in July, under the 0.4% increase expected by analysts, according to Office for National Statistics. The ONS also released figures showing that while UK public finances improved last month borrowing still remains above the government's target.Looking ahead to the US session, stock futures on Wall Street were edging higher in pre-market trade ahead of a host of economic data, including jobless claims, the Markit manufacturing PMI, existing-home sales and the Philadelphia Fed index.Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later on with comments from policymakers around the world likely to be closely watched.Mining stocks fallWeak data from top metals consumer China and falling metal prices dampened the demand for mining stocks on Wednesday with Fresnillo, Randgold, Rio Tinto, Anglo American and BHP Billiton trading lower.BHP Billiton was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm could have "irritated" some who are not mandated to hold investments in Australia. Kazakh metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but shares fell sharply after it said 2014 gold production was likely to fall short of hopes.Oil and gas stocks were also out of favour including Ophir Energy, Tullow and Shell.Premier Oil was more or less flat after saying it had a "strong six months" with better-than-expected production leading to higher revenues and cash flows. However, it saw a sharp reduction in pre-tax profit in the first half due to impairments.Leading the upside in London were a raft of pharmaceutical and biotechnology stocks, including Astrazeneca, Glaxosmithkline, Shire and Hikma Pharmaceuticals.Financials such as Schroders, Aviva, Old Mutual and Hargreaves Lansdown were also providing a lift.FTSE 100 - RisersSchroders (SDR) 2,385.00p +2.36%AstraZeneca (AZN) 4,372.50p +2.04%GlaxoSmithKline (GSK) 1,438.00p +1.45%CRH (CRH) 1,391.00p +1.31%Ashtead Group (AHT) 945.50p +1.23%Old Mutual (OML) 196.20p +1.13%Barratt Developments (BDEV) 363.50p +1.08%Aviva (AV.) 521.00p +1.07%Diageo (DGE) 1,769.00p +1.00%Hargreaves Lansdown (HL.) 1,120.00p +0.99%FTSE 100 - FallersFresnillo (FRES) 938.50p -3.50%Kingfisher (KGF) 306.60p -1.73%Anglo American (AAL) 1,576.50p -1.10%Randgold Resources Ltd. (RRS) 4,947.00p -1.00%Royal Mail (RMG) 441.80p -0.88%Antofagasta (ANTO) 812.00p -0.85%Rio Tinto (RIO) 3,430.00p -0.81%Standard Chartered (STAN) 1,211.50p -0.78%Pearson (PSON) 1,120.00p -0.71%easyJet (EZJ) 1,330.00p -0.67%FTSE 250 - RisersRank Group (RNK) 166.00p +3.49%Imagination Technologies Group (IMG) 204.90p +3.48%Hikma Pharmaceuticals (HIK) 1,740.00p +2.84%Domino Printing Sciences (DNO) 647.00p +2.70%International Personal Finance (IPF) 519.00p +2.57%Amlin (AML) 439.00p +2.26%Fisher (James) & Sons (FSJ) 1,366.00p +2.25%Euromoney Institutional Investor (ERM) 1,073.00p +2.19%Senior (SNR) 287.70p +2.17%Xaar (XAR) 558.50p +2.10%FTSE 250 - FallersKazakhmys (KAZ) 292.90p -5.06%Thomas Cook Group (TCG) 119.80p -3.39%Just Retirement Group (JRG) 145.30p -3.20%Hochschild Mining (HOC) 162.20p -2.29%Centamin (DI) (CEY) 62.85p -2.26%Petra Diamonds Ltd.(DI) (PDL) 186.80p -2.05%Ophir Energy (OPHR) 225.20p -1.96%African Barrick Gold (ABG) 240.30p -1.52%Serco Group (SRP) 305.10p -1.39%Stock Spirits Group (STCK) 290.50p -1.36%BC
More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.